Trial intelligence / Profile preview

Diazepam vs Placebo in Acute Peripheral Vertigo

NCT06293989Phase 3Not yet recruiting

Sponsor
Université de Monastir
Start
May 2024
Primary completion
Dec 2025
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of diazepam in Peripheral vertigo (3 arms), sponsored by Université de Monastir. Primary endpoint: Visual Analogue Scale at 3 hours. Planned start May 2024; status: not yet recruiting.

02

Drugs

diazepam
03

Conditions

Peripheral vertigo

Beyond the preview

Go deeper on NCT06293989.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06293989.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call